What's breaking now, across thousands of outlets.
A Chinese biotech is selling the Japanese rights for its Phase 3 thyroid eye disease drug to a 106-year-old specialty pharma long known for its thyroid hormone business. Shanghai-based Minghui Pharmaceutical will ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Two cancer vaccines from Hong Kong-based Sequencio Therapeutics have been selected for presentation at a major US conference, as companies bet on therapies based on ribonucleic acid (RNA) to deliver…
Have you ever gone to pick up a prescription only to discover you have no refills left? The pharmacy must contact your doctor for authorization before it can fill the […]
Following confirmation of the presence of the poliovirus in Jamali Colony, the Karachi administration and the Emergency Operations Centre (EOC) have decided to further strengthen the anti-polio…
What is the Total Fertility Rate of India? How does it impact policy interventions?
What is the Total Fertility Rate of India? How does it impact policy interventions?
